Target type: biologicalprocess
Any process that modulates the frequency, rate or extent of muscle contraction of the hindgut, the posterior part of the alimentary canal, including the rectum, and the large intestine. [GOC:jl, UBERON:0001046]
The regulation of hindgut contraction is a complex process involving a coordinated interplay of neural, hormonal, and muscular components. The hindgut, the final portion of the digestive tract, is responsible for absorbing water and electrolytes and propelling waste materials toward elimination.
**Neural Regulation:**
- The enteric nervous system (ENS), a complex network of neurons within the gut wall, plays a key role in controlling hindgut motility.
- **Myenteric plexus** neurons, located between the muscle layers, are responsible for regulating the strength and frequency of contractions.
- **Submucosal plexus** neurons control the secretion of fluids and regulate blood flow.
- **Extrinsic nerves** from the autonomic nervous system also influence hindgut motility. Sympathetic nerves generally inhibit contractions, while parasympathetic nerves promote them.
**Hormonal Regulation:**
- **Gastrointestinal hormones** such as gastrin, cholecystokinin (CCK), and motilin can influence hindgut contraction.
- **Gastrin** stimulates contraction in the distal hindgut, while **CCK** inhibits contraction.
- **Motilin** promotes rhythmic contractions known as migrating motor complexes (MMCs) that sweep the gut clear of debris.
**Muscular Mechanisms:**
- The hindgut wall contains smooth muscle cells that contract and relax to propel contents.
- **Circular muscle** fibers encircle the gut lumen and their contraction constricts the diameter, while **longitudinal muscle** fibers run along the length of the gut and their contraction shortens the gut.
- **Neurotransmitters**, such as acetylcholine and norepinephrine, released by nerve terminals act on these muscle cells to regulate contraction.
- **Calcium ions** play a crucial role in triggering muscle contraction.
**Factors Influencing Hindgut Contraction:**
- **Dietary composition:** The type and amount of food consumed can influence hindgut motility.
- **Stress levels:** Psychological stress can alter gut function, including hindgut contraction.
- **Disease states:** Conditions like irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) can disrupt normal hindgut motility.
**Summary:**
The regulation of hindgut contraction is a finely tuned process involving complex interactions between neural, hormonal, and muscular components. This intricate network ensures efficient waste elimination and contributes to overall digestive health.'
"
Protein | Definition | Taxonomy |
---|---|---|
Growth hormone secretagogue receptor type 1 | A growth hormone secretagogue receptor that is encoded in the genome of human. [PRO:WCB, UniProtKB:Q92847] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
substance p | peptide | neurokinin-1 receptor agonist; neurotransmitter; vasodilator agent | |
l 692429 | L 692429: stimulates release of growth hormone; RN refers to (R)-isomer; structure given in first source | ||
l 163191 | |||
cp 424391 | CP 424391: a growth hormone secretagogue; structure in first source | ||
hexarelin | hexarelin: a synthetic growth hormone releasing peptide; structurally similar to GHRP-6, with the substitution of D-Trp with its 2-methyl derivative; more potent & stable and less toxic than GHRP-6 | ||
sm 130686 | SM 130686: a growth hormone secretagogue; structure in first source | ||
macimorelin | |||
tabimorelin | tabimorelin: a growth hormone secretagogue; structure in first source | ||
l 162752 | |||
sk&f 110679 | |||
ulimorelin | ulimorelin: ghrelin agonist; an 18-membered macrocycle containing 3 amide bonds and a secondary amine as well as 4 stereogenic centers; belongs to macrocyclic peptidomimetics | oligopeptide | |
n-(3-fluorophenyl)-1-((4-(((3s)-3-methyl-1-piperazinyl)methyl)phenyl)acetyl)-4-piperidinamine | N-(3-fluorophenyl)-1-((4-(((3S)-3-methyl-1-piperazinyl)methyl)phenyl)acetyl)-4-piperidinamine: a small molecule motilin receptor agonist; structure in first source | acetamides | |
yil 781 | YIL 781: an appetite suppressant and weight loss promoter; structure in first source | ||
nitd 609 | NITD 609: an antimalarial and coccidiostat; structure in first source | ||
gsk 2334470 | GSK 2334470: a PDK1 inhibitor; structure in first source | indazoles |